Zobrazeno 1 - 4
of 4
pro vyhledávání: '"SOFAS, Social and Occupational Functioning Assessment Scale"'
Autor:
Daiki Sasabayashi, Yuko Higuchi, Haruko Kobayashi, Yoichiro Takayanagi, Atsushi Furuichi, Kyo Noguchi, Shimako Nishiyama, Michio Suzuki, Tien Viet Pham, Tsutomu Takahashi, Yukiko Akasaki, Yuko Mizukami
Publikováno v:
NeuroImage : Clinical
NeuroImage: Clinical, Vol 32, Iss, Pp 102805-(2021)
NeuroImage: Clinical, Vol 32, Iss, Pp 102805-(2021)
Highlights • Pineal morphology was investigated in schizophrenia patients and ARMS subjects. • Pineal volumes were significantly smaller in both groups than in healthy controls. • Pineal cysts were associated with clinical symptomatology in sch
Autor:
Tsutomu Takahashi, Shimako Nishiyama, Yuko Komori, Michio Suzuki, Yuko Higuchi, Tomiki Sumiyoshi, Motomu Suga, Kiyoto Kasai, Tomonori Seo
Publikováno v:
Schizophrenia Research: Cognition
Schizophrenia Research: Cognition, Vol 7, Iss C, Pp 13-18 (2017)
Schizophrenia Research: Cognition, Vol 7, Iss C, Pp 13-18 (2017)
Cognitive function is impaired in patients with schizophrenia-spectrum disorders, even in their prodromal stages. Specifically, the assessment of cognitive abilities related to daily-living functioning, or functional capacity, is important to predict
Autor:
Guo, Joyce Y., Huhtaniska, Sanna, Miettunen, Jouko, Jääskeläinen, Erika, Kiviniemi, Vesa, Nikkinen, Juha, Moilanen, Jani, Haapea, Marianne, Mäki, Pirjo, Jones, Peter B., Veijola, Juha, Isohanni, Matti, Murray, Graham K.
Publikováno v:
Schizophrenia Research
Background Progressive brain volume loss in schizophrenia has been reported in previous studies but its cause and regional distribution remains unclear. We investigated progressive regional brain reductions in schizophrenia and correlations with pote
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::18490cce26694659b20e638442be8ef2
https://www.repository.cam.ac.uk/handle/1810/248937
https://www.repository.cam.ac.uk/handle/1810/248937
Autor:
Higuchi Y; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Sumiyoshi T; Department of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Japan., Seo T; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Suga M; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan.; Department of Rehabilitation, The University of Tokyo Hospital, Japan., Takahashi T; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Nishiyama S; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Komori Y; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan., Kasai K; Department of Neuropsychiatry, Graduate School of Medicine, The University of Tokyo, Japan., Suzuki M; Department of Neuropsychiatry, University of Toyama Graduate School of Medicine and Pharmaceutical Sciences, 2630 Sugitani, Toyama 930-0194, Japan.
Publikováno v:
Schizophrenia research. Cognition [Schizophr Res Cogn] 2017 Feb 22; Vol. 7, pp. 13-18. Date of Electronic Publication: 2017 Feb 22 (Print Publication: 2017).